Improving Emotion Dysregulation and Interpersonal Conflict Among Families of Adolescents With ADHD

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study consists of a randomized controlled trial assessing the acceptability, feasibility, and efficacy of the RELAX (Regulating Emotions Like An eXpert) Intervention. Following randomization, 30 families will receive the RELAX intervention and 30 families will receive psychoeducational materials as part of a control condition. Additionally, 10 families from the RELAX condition will participate in a pilot study and focus groups to give feedback on developed smartphone apps to support skill use during and following completion of RELAX.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 11
Maximum Age: 16
Healthy Volunteers: f
View:

• child with ADHD in middle or high school at time of study entry

• child has an estimated verbal IQ \>=80 based on the Wechsler Intelligence Scale for Children, Fifth Edition Verbal Comprehension Index

• child has no evidence of severe developmental delay either from genetic origins (e.g., Down Syndrome) or complications during pregnancy/birth (e.g., infection, micropremature)

• participating parent/legal guardian has custody/medical decision making of the child

• family uses English as one of their primary languages (i.e., able to participate in study visits and intervention conducted in English)

Locations
United States
Virginia
Child Study Center
RECRUITING
Blacksburg
Contact Information
Primary
Rosanna Breaux, PhD
calmerlab@gmail.com
5402318276
Time Frame
Start Date: 2025-01-15
Estimated Completion Date: 2028-12
Participants
Target number of participants: 60
Treatments
Experimental: RELAX Intervention
group-based RELAX telehealth intervention
Active_comparator: Psychoeducational Waitlist Control
The psychoeducational component will consist of infographics regarding emotion regulation strategies and managing interpersonal conflict.
Sponsors
Leads: Virginia Polytechnic Institute and State University

This content was sourced from clinicaltrials.gov